GlassScriptPhysician profile
Thomas M Ward
NPI 1871949768
$1,987.11
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $47.62 · 2024: $1,715 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $702 · Travel and Lodging: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $702.19 |
| Travel and Lodging | $284.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,447.42 | 2024 | |
| Kerecis Limited | $138.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Applied Medical Resources Corporation | $92.93 | 2024 | Gelport Laparoscopic System |
| Baxter Healthcare | $47.62 | 2023 | Hillrom - Fcs 700 Boom |
| Ethicon US, LLC | $36.57 | 2025 | Echelon Flex, Echelon Circular |
| Sobi, INC | $36.46 | 2024-2025 | |
| Medtronic, INC. | $26.72 | 2025 | Signia |
| Sumitomo Pharma America, INC. | $20.19 | 2025 | Orgovyx |
| Syndax Pharmaceuticals, INC. | $19.88 | 2025 | |
| Pfizer INC. | $19.07 | 2025 | |
| Kite Pharma, INC. | $18.89 | 2025 | Yescarta |
| Smith+Nephew, INC. | $18.73 | 2025 | Stravix, Grafix Pl |
| Rigel Pharmaceuticals, INC. | $18.69 | 2024 | Tavalisse, Rezlidhia |
| Conmed Corporation | $16.81 | 2025 | Airseal |
| Emd Serono, INC. | $14.48 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.